| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.07 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.07 |